First Nitrosamine Implementation Oversight Group (NIOG) - meeting with pharmaceutical industry

Date: 31/03/2021

Event summary

The Nitrosamine Implementation Oversight Group (NIOG) was set up by the European medicines regulatory network to oversee the harmonised implementation of the Article 5(3) CHMP opinion on nitrosamines in human medicinal products.

The NIOG will be the main interface between regulators and industry to agree on topics requiring further scientific discussion.

This is the first meeting of the NIOG with industry stakeholders. The aim is to explain the NIOG's mandate and operating methods, and to future interactions with industry on specific nitrosamine-related topics.


  • Registration by invitation only

How useful was this page?

Add your rating
1 rating